ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

IVF vs NXGL // 10Y YIELD & FRED MACRO BETA

INVO Fertility Inc. (NASDAQ) VS. NexGel Inc (NASDAQ) • 15-METRIC TALLY: IVF 3 — NXGL 3
■ METRIC PARITY
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IVF VS. NXGL) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC IVF NXGL SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 96.00% 39.50% +56.50 IVF /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -29.30% -30.70 NXGL /operating-margins <GO>
Net Profit Margin 68.00% -26.30% +94.30 IVF /net-margins <GO>
Revenue Growth (YoY) 4.30% 31.50% -27.20 NXGL /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 5/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 14.3 43.0 -28.70 NXGL /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.5M $1.9M $575.7K IVF /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR IVF REV NXGL REV IVF GROSS % NXGL GROSS % IVF FCF NXGL FCF
FY 2025 $6.8M $11.4M 98.0% 39.5% -$7.1M -$1.4M
FY 2024 $6.6M $8.7M 43.3% 31.6% -$3.2M -$4.3M
FY 2023 $3.0M $4.1M — — -$4.8M -$3.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IVF // BETA —
NXGL // BETA —